Michael Robert A.
SEC CIK 1699914 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | Vice COB | 178.7K | — | $18.54M | 13 | 2022-02-17 | 2026-02-27 |
Most active insiders at ABBV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Siatis Perry C | EVP, GC AND Sec | — | $9.52M |
| 2 | Donoghoe Nicholas | EVP, CHIEF BUS, STRAT Off | — | $8.18M |
| 3 | Purdue David Ryan | SVP, Ctrl | — | $1.22M |
| 4 | Crum Demetris D | EVP, Chief HR Off | — | — |
| 5 | Thakkar Roopal | EVP, CSO, R, D | — | — |
| 6 | Quaggin Susan E | Dir | — | — |
| 7 | Reents Scott T | EVP, CFO | — | — |
| 8 | Davis Jennifer L. | Dir | — | — |
| 9 | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | — | — |
| 10 | MEYER MELODY B | Dir | — | — |
| 11 | Michael Robert A. | COB AND CEO, Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-02-27 | ABBV | AbbVie | Michael Robert A. | COB AND CEO, Dir | F - Tax | $232.08 | -36.5K | 178.7K | -17% | -$8.48M | |
| DM | 2026-02-20 | 2026-02-18 | ABBV | AbbVie | Michael Robert A. | CEO, Dir | A - Grant | $0.00 | +82.4K | 215.3K | +62% | $0 |
| 2025-03-04 | 2025-02-28 | ABBV | AbbVie | Michael Robert A. | CEO, Dir | F - Tax | $205.02 | -27.2K | 132.8K | -17% | -$5.57M | |
| DM | 2025-02-18 | 2025-02-13 | ABBV | AbbVie | Michael Robert A. | CEO, Dir | A - Grant | $0.00 | +61.4K | 145.6K | +73% | $0 |
| D | 2024-03-01 | 2024-02-28 | ABBV | AbbVie | Michael Robert A. | Pres, COO | F - Tax | $178.99 | -37.6K | 146.0K | -20% | -$6.74M |
| DM | 2024-03-01 | 2024-02-29 | ABBV | AbbVie | Michael Robert A. | Pres, COO | M - OptEx | $58.30 | +21.6K | 167.5K | +15% | +$1.26M |
| DM | 2024-03-01 | 2024-02-29 | ABBV | AbbVie | Michael Robert A. | Pres, COO | S - Sale+OE | $176.45 | -68.9K | 98.6K | -41% | -$12.15M |
| DM | 2024-02-20 | 2024-02-15 | ABBV | AbbVie | Michael Robert A. | Pres, COO | A - Grant | $0.00 | +85.0K | 183.6K | +86% | $0 |
| 2023-03-02 | 2023-02-28 | ABBV | AbbVie | Michael Robert A. | VICE COB | F - Tax | $154.28 | -48.3K | 98.6K | -33% | -$7.46M | |
| DM | 2023-02-21 | 2023-02-16 | ABBV | AbbVie | Michael Robert A. | VICE COB | A - Grant | $0.00 | +109.1K | 136.8K | +393% | $0 |
| 2022-03-01 | 2022-02-25 | ABBV | AbbVie | Michael Robert A. | Vice COB | F - Tax | $149.54 | -34.3K | 81.0K | -30% | -$5.13M | |
| M | 2022-03-01 | 2022-03-01 | ABBV | AbbVie | Michael Robert A. | Vice COB | S - Sale | $148.25 | -43.1K | 37.9K | -53% | -$6.39M |
| DM | 2022-02-22 | 2022-02-17 | ABBV | AbbVie | Michael Robert A. | Vice COB | A - Grant | $0.00 | +77.4K | 78.6K | +6,266% | $0 |
Purchase Sale Sale after option exercise All abbreviations